Kazuhiro Tokimasa

HuBit Genomix KK is a Japanese pharmaceutical development company that conducts clinical trials and research on pharmaceuticals to develop diagnostic drugs. The company is based in Tokyo, Japan. The company analyzes and utilize valuable information to create "diagnosis methods" and "pharmaceuticals" that satisfy medical amenities. HuBit Genomix KK was acquired by Celera Group on March 20, 2001.

Jasdaq Securities Exchange, Inc. operates security and commodity exchange services. It offers auction and market maker methods for venture companies. The company was founded in June 01, 1976 and is headquartered in Tokyo, Japan.

Part of Metareal Corp., Glova KK is a Japanese company that provides translation services and translator temporary staffing services. The company is based in Tokyo, Japan.

K-Engine Corp. is a holding company that provides information technology (IT) solutions. It specializes in IT cloud services for the housing industry. The firm develops ReformPlanner, a smart phone application that allows users to design, plan, and reform a house interior. Its platform also enables the users to purchase housing furniture and request for fixture installation online. The company was founded on August 9, 2011 and is headquartered in Tokyo, Japan.

BioComo, Inc. is a biotech company founded in Mie Prefecture, Japan in 2008. The private company is developing cutting-edge technology platforms for creating novel vaccine carriers and adjuvants to enhance immunity in collaboration with the microbiology and molecular genetics department of Mie University. The Japanese company's technology has already succeeded in the development of highly efficacious and state-of-the-art vaccine carrier and novel adjuvant candidates. The company's technology will be applied to the production of the next generation vaccines for the prevention of infections such as RS virus, Ebola virus, influenza virus, and SARS-CoV-2, enabling faster and cost-effective production of those vaccines. BC-PIV is the core platform technology which was named after the corporate name, BioComo, and the leading vaccine carrier which is derived from the recombinant human parainfluenza virus 2 (HPIV2) vectors.

Founded in 2020, Matrix, Inc. /JP/ is a subsidiary of Metareal Corp. that is based in Tokyo, Japan. The Japanese company's mission is to create a world without borders, language barriers, appearance discrimination, body limitations, or knowledge gaps. The company aims to achieve this by creating the ideal village of mankind through their innovative product, the "anywhere door". On March 1, 2021, Matrix, Inc. /JP was acquired by Metareal Corp. for $0.47 million.

Xtra, Inc. engages in web translation services. It develops and operates Conyac, a social, human powered translation platform. It enables users to request a translation or translate a request by another user. The company was founded by Naoki Yamada and Tomohiro Onuma on February 9, 2009 and is headquartered in Tokyo, Japan.